- Investing Ideas
- /
- U.S. Healthcare Large Cap High Growth Potential
U.S. Healthcare Large Cap High Growth Potential
Results
10
1 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
10 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
DXCM | US$80.04 | 3.7% | -34.5% | US$29.6b | US$96.26 | PE45.9x | E16.6% | n/a | ||
UNH | US$500.13 | -3.9% | -3.9% | US$450.2b | US$636.05 | PE32.1x | E24.5% | 1.7% | ||
BSX | US$88.95 | -1.3% | 59.1% | US$131.1b | US$99.00 | PE73.1x | E23.3% | n/a | ||
BAX | US$29.50 | -2.7% | -23.1% | US$15.1b | US$40.69 | PE124.5x | E40.5% | 2.3% | ||
GMED | US$82.63 | 0.3% | 54.0% | US$11.2b | US$94.23 | PE122.9x | E49.5% | n/a | ||
CI | US$276.92 | -1.8% | -7.1% | US$77.0b | US$396.77 | PE25.3x | E24.2% | 2.0% | ||
SWAV | US$334.75 | 0.2% | 15.8% | US$12.6b | US$326.05 | PE76.9x | E18.4% | n/a | ||
DOCS New | US$57.83 | 10.9% | 107.1% | US$10.3b | US$55.24 | PE62x | E9.4% | n/a | ||
LH | US$228.61 | -1.5% | 2.0% | US$19.0b | US$262.88 | PE43.9x | E21.9% | 1.3% | ||
MOH | US$294.73 | -2.7% | -17.8% | US$16.9b | US$364.63 | PE14.7x | E14.7% | n/a |
Page 1 of 1